IP Library Assignment 016621/0924
Patent Assignment
Reel/Frame 016621/0924

Assignment of Assignor's Interest

Recorded: 2005-06-02 Pages: 4
Assignors
TOBINICK, EDWARD L.
Executed: 2005-05-23
TOBINICK, ARTHUR JEROME
Executed: 2005-05-23
Assignee
TACT IP, LLC
SUITE 1004, 2901 SOUTH OCEAN BLVD., HIGHLAND BEACH, FLORIDA, 33487
Covered Properties (18)
Tumor Necrosis Factor Antagonists for the Treatment of Neurological Disorders
Patent: 6,015,557 →
Application: 09/275,070 →
Tnf Inhibitors for the Treatment of Neurological
Patent: 6,177,077 →
Application: 09/476,643 →
Interleukin Antagonists for the Treatment of Neurological, Retinal and Muscular Disorders
Patent: 6,471,961 →
Application: 09/563,651 →
Tnf Modulators for Treating Neurological Disorders Associated with Viral Infection
Patent: 6,419,934 →
Application: 09/654,996 →
Tnf Inhibitors for the Treatment of Retinal Disorders
Patent: 6,428,787 →
Application: 09/665,529 →
Tnf Inhibitors for the Treatment of Neurological, Retinal and Muscular Disorders
Patent: 6,379,666 →
Application: 09/666,068 →
Cytokine Antagonists for the Treatment of Sensorineural Hearing Loss
Patent: 6,423,321 →
Application: 09/749,189 →
Publication: US 2001/0004456
Cytokine Antagonists for the Treatment of Localized Disorders
Patent: 6,419,944 →
Application: 09/826,976 →
Publication: US 2001/0016195
Cytokine Antagonists for the Treatment of Localized Disorders
Patent: 6,537,549 →
Application: 09/841,844 →
Publication: US 2001/0026801
Fuel Cell Drive System
Patent: 6,641,944 →
Application: 09/973,985 →
Publication: US 2002/0045078
Interleukin antagonists for the treatment of neurological, retinal and muscular disorders
Application: 10/152,476 →
Publication: US 2002/0131954
Interleukin Antagonists for the Treatment of Neurological, Retinal and Muscular Disorders
Patent: 6,623,736 →
Application: 10/152,477 →
Publication: US 2002/0131955
Cytokine antagonists and other biologics for the treatment of bone metastases
Application: 10/236,097 →
Publication: US 2003/0007972
Cytokine Antagonists for Neurological and Neuropsychiatric Disorders
Patent: 6,982,089 →
Application: 10/269,745 →
Publication: US 2003/0049256
TNF inhibition for the treatment of pre-menstrual syndrome and primary dysmenorrhea
Application: 10/340,890 →
Publication: US 2003/0113318
Cytokine antagonists for the treatment of localized disorders
Application: 10/393,540 →
Publication: US 2003/0185826
Method of Delivering a Tnf Antagonist to the Brain of a Human by Perispinal Administration Without Direct Intrathecal Injection
Patent: 7,214,658 →
Application: 11/016,047 →
Publication: US 2006/0009450
Etanercept for treatment or prevention of cognitive impairment, alzheimer's disease, and other clinical disorders
Application: 60/585,735 →
Related Assignments (3)
Other recorded transfers of the patents in this record — the chain of ownership.
Assignment of Assignor's Interest Nov 20, 2000
From: BRYANT, ZACHARY H.
To: LANE COMPANY, INCORPORATED, THE
Reel/Frame 011317/0920 →
Assignment of Assignor's Interest Dec 6, 2001
From: KAWASUMI, EMI; IWASAKI, YASUKAZU
To: NISSAN MOTOR CO., LTD.
Reel/Frame 012348/0333 →
Address Change Oct 4, 2017
From: TACT IP, LLC
To: TACT IP, LLC
Reel/Frame 044127/0229 →